120 Participants Needed

Culturally Informed Care Coordination for Kidney Disease

KA
MR
Overseen ByMerle R. Kataoka-Yahiro, DrPH, MPH, MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Hawaii
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Culturally informed care coordination intervention for kidney disease?

Research shows that culturally tailored interventions, like using community health workers and patient navigators, can improve health outcomes for ethnic minorities with chronic kidney disease by addressing social challenges and enhancing patient education. These approaches have been effective in other conditions, such as cancer care, and show promise in improving care for kidney disease patients from diverse backgrounds.12345

Is culturally informed care coordination for kidney disease safe for humans?

The research articles reviewed do not provide specific safety data for culturally informed care coordination interventions for kidney disease. However, these interventions generally focus on education and support, which are typically safe approaches.12346

How does the culturally informed care coordination treatment for kidney disease differ from other treatments?

This treatment is unique because it focuses on culturally tailored interventions, using community-based patient navigators and community health workers to address social challenges and improve outcomes for ethnic minorities with kidney disease. Unlike standard treatments, it emphasizes cultural and linguistic concordance to bridge gaps between patients and the healthcare system.12345

What is the purpose of this trial?

Native Hawaiians (NH) are 9.5 times more likely to be on dialysis or need a kidney transplant compared to Whites. They have the highest end-stage kidney disease (ESKD) incidence rates in the nation, begin dialysis at younger ages (30-50 years), and one of the most under-studied racial/ethnic groups in chronic kidney disease (CKD) research. This project's outcome is to improve kidney disease follow-up among early stage NHs at high risk by aligning health equity with a culturally appropriate care coordination systems model.

Research Team

MR

Merle R Kataoka-Yahiro, DrPH., MPH., MS.

Principal Investigator

University of Hawaii at Manoa

Eligibility Criteria

This trial is for Native Hawaiians who are at high risk of kidney disease, particularly those in the early stages. It aims to improve follow-up care by using a culturally appropriate care coordination model.

Inclusion Criteria

Native Hawaiian (NH) participants from the NKFH KEDS program self-report as Native Hawaiian
Native Hawaiian (NH) participants from the NKFH KEDS program have participated in the NKFH KEDS Program within 3 months
I am Native Hawaiian with kidney function below normal or have high protein in my urine.

Exclusion Criteria

Not applicable.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Formative Evaluation

Conduct a formative evaluation on the barriers and facilitators of care coordination and follow-up for eGFR and UACR among participants and staff.

12 months

Intervention Evaluation

Evaluate the acceptability and feasibility of a culturally-informed care coordination intervention at selected PCP sites.

6 months

Follow-up

Participants are monitored for the effectiveness of the intervention and re-screening rates.

9 months

Treatment Details

Interventions

  • Culturally informed care coordination intervention
Trial Overview The study is testing a culturally informed care coordination intervention against usual care practices to see if it can better manage kidney disease among Native Hawaiians.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Culturally Informed Care CoordinationExperimental Treatment2 Interventions
In this ARM, we will trial the culturally informed care coordination intervention to see if improves patient care follow-up
Group II: Usual Care GroupActive Control1 Intervention
In this Arm the Usual Care Group does not have an intervention.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Hawaii

Lead Sponsor

Trials
122
Recruited
55,200+

National Kidney Foundation

Collaborator

Trials
33
Recruited
85,800+

National Kidney Foundation, United States

Collaborator

National Kidney Foundation

Collaborator

Findings from Research

Latinx populations experience higher rates of kidney failure compared to non-Latinx Whites, despite similar rates of chronic kidney disease (CKD), highlighting the need for targeted interventions.
Community health worker (CHW) programs can improve outcomes for Latinx individuals with kidney disease by building trust, allowing participant input, and using trauma-informed approaches, but face challenges like systemic barriers and low recruitment, necessitating further research on their effectiveness.
Proceedings of a Workshop to Promote Community Health Worker Interventions in Nephrology.Novick, TK., Cervantes, L., Golestaneh, L., et al.[2023]

References

Patient Navigation: Addressing Social Challenges in Dialysis Patients. [2021]
Proceedings of a Workshop to Promote Community Health Worker Interventions in Nephrology. [2023]
Interventions to support decision-making, health literacy and self-management in ethnic-minority adults living with chronic kidney disease: a systematic review. [2023]
Community-Engaged Research (CEnR) to Address Gaps in Chronic Kidney Disease Education among Underserved Latines-The CARE Study. [2023]
A codesigned integrated kidney and diabetes model of care improves patient activation among patients from culturally and linguistically diverse backgrounds. [2023]
A Website Intervention to Increase Knowledge About Living Kidney Donation and Transplantation Among Hispanic/Latino Dialysis Patients. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security